The Food and Drug Administration gave emergency authorization to Ellume's rapid test in December, after it showed 96% accuracy in a U.S. clinical study.
Copyright 2021 NPR
Bill Chappell is a writer and editor on the News Desk in the heart of NPR's newsroom in Washington, D.C.
Selena Simmons-Duffin reports on health policy for NPR.